On November 8, 2023 Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) reported that Dr Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies London Healthcare Conference 2023 (Press release, Telix Pharmaceuticals, NOV 8, 2023, View Source [SID1234637290]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will take place on Wednesday 15 November from 4:00 – 4:30pm GMT (11:00am EST / 3:00am AEDT, 16 November).

Participants can register for the webcast at the following link: View Source

The webcast will be accessible on demand on the Telix website following the event.